📊 CELC Key Takeaways
Is Celcuity Inc. (CELC) a Good Investment?
Celcuity is a pre-revenue or severely revenue-challenged medical laboratory company burning substantial cash with negative operating income of -$123M and negative free cash flow of -$117.1M. Despite adequate liquidity ($74.3M cash), the company is not generating any revenue to support operations, indicating either a business model failure or extremely early-stage development without demonstrated commercialization capability.
Celcuity’s fundamentals remain weak: the company is still effectively pre-revenue, with large operating and net losses and deeply negative operating cash flow. Its balance sheet provides some near-term support through high liquidity, but leverage is meaningful and the current cash burn rate raises concerns about funding durability unless clinical and commercialization milestones materially improve.
Why Buy Celcuity Inc. Stock? CELC Key Strengths
- Strong current ratio of 12.26x indicates sufficient short-term liquidity to cover operational burn
- Cash position of $74.3M provides runway for operations, though burn rate suggests limited duration
- Recent Form 4 filings show 3 insider transactions indicating some management activity
- Very strong near-term liquidity, with current and quick ratios of 12.26x
- Large asset base relative to current operating scale, supporting ongoing development efforts
- Low capital expenditure needs keep cash usage concentrated in core operations rather than heavy fixed investment
CELC Stock Risks: Celcuity Inc. Investment Risks
- Zero or near-zero revenue with massive operating losses (-$123M) signals fundamental business model issues or failed commercialization
- Negative free cash flow of -$117.1M represents severe cash burn that will rapidly deplete the $74.3M cash reserve (approximately 7.7 months of runway)
- Negative ROE of -107.8% and ROA of -26.5% indicate shareholder value destruction; long-term debt of $137.2M creates leverage risk when combined with zero revenue generation
- No profitability metrics available (N/A margins) reflects inability to achieve gross profit, suggesting operational failure to generate positive contribution margins
- No meaningful revenue base, limiting visibility into sustainable business economics
- Heavy annual cash burn, with negative operating cash flow of $116.88M and free cash flow of $117.08M
- Leverage is elevated for a loss-making company, with debt/equity of 1.17x and negative interest coverage
Key Metrics to Watch
- Quarterly revenue generation and path to positive gross profit
- Operating cash burn rate and cash runway remaining
- Long-term debt refinancing obligations and ability to service debt without revenue
- Quarterly operating cash burn relative to cash and equivalents
- Any emergence of sustainable revenue and narrowing operating losses
Celcuity Inc. (CELC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 12.26x current ratio provides a solid financial cushion.
CELC Profit Margin, ROE & Profitability Analysis
CELC vs Healthcare Sector: How Celcuity Inc. Compares
How Celcuity Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Celcuity Inc. Stock Overvalued? CELC Valuation Analysis 2026
Based on fundamental analysis, Celcuity Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Celcuity Inc. Balance Sheet: CELC Debt, Cash & Liquidity
CELC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Celcuity Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.83 indicates the company is currently unprofitable.
CELC Revenue Growth, EPS Growth & YoY Performance
Celcuity Inc. Dividends, Buybacks & Capital Allocation
CELC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Celcuity Inc. (CIK: 0001603454)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CELC
What is the AI rating for CELC?
Celcuity Inc. (CELC) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 87% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CELC's key strengths?
Claude: Strong current ratio of 12.26x indicates sufficient short-term liquidity to cover operational burn. Cash position of $74.3M provides runway for operations, though burn rate suggests limited duration. ChatGPT: Very strong near-term liquidity, with current and quick ratios of 12.26x. Large asset base relative to current operating scale, supporting ongoing development efforts.
What are the risks of investing in CELC?
Claude: Zero or near-zero revenue with massive operating losses (-$123M) signals fundamental business model issues or failed commercialization. Negative free cash flow of -$117.1M represents severe cash burn that will rapidly deplete the $74.3M cash reserve (approximately 7.7 months of runway). ChatGPT: No meaningful revenue base, limiting visibility into sustainable business economics. Heavy annual cash burn, with negative operating cash flow of $116.88M and free cash flow of $117.08M.
What is CELC's revenue and growth?
Celcuity Inc. reported revenue of N/A.
Does CELC pay dividends?
Celcuity Inc. does not currently pay dividends.
Where can I find CELC SEC filings?
Official SEC filings for Celcuity Inc. (CIK: 0001603454) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CELC's EPS?
Celcuity Inc. has a diluted EPS of $-2.81.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CELC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Celcuity Inc. has a SELL rating with 87% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CELC stock overvalued or undervalued?
Valuation metrics for CELC: ROE of -107.8% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy CELC stock in 2026?
Our dual AI analysis gives Celcuity Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CELC's free cash flow?
Celcuity Inc.'s operating cash flow is $-116.9M, with capital expenditures of $196.0K.
How does CELC compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -107.8% (avg: 15%), current ratio 12.26 (avg: 2).